Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot186210.32687/0869-866X-2023-31-4-509-518Научная статьяTHE ASSESSMENT OF EFFICIENCY OF IMPLEMENTATION OF THE FEDERAL PROJECT “THE STRUGGLE WITH CARDIOVASCULAR DISEASES” DURING COVID-19 PANDEMICPerkhovV.I.KudelinaO.V.KorkhmazovV.T.The Federal State Budget Institution “The Central Research Institute for Health Organization and Informatics” of Minzdrav of Russia, 127254, Moscow, RussiaThe Federal State Budget Educational Institution of Higher Education “The Siberian State Medical University” of Minzdrav of Russia, 634050, Tomsk, RussiaThe Federal State Budget Educational Institution of Higher Education “The Kuban State Medical University” of Minzdrav of Russia, 350063, Krasnodar, Russia2508202331450951803072025Copyright © 2023,2023The article presents assessment of efficiency of implementation of the Federal project “The struggle with cardiovascular diseases” during COVID-19 pandemic. It is demonstrated that over three years of implementation of the Federal project significant consolidation of medical infrastructure and volume of work of regional vascular departments and centers took place. However, these achievements resulted in no improvement of quality of medical care nor in decreasing of mortality from diseases of the circulatory system. According to results of integral assessment, there is trend of pronounced decreasing in the number of subjects of the Russian Federation with average and high indicators of project efficiency when the COVID-19 pandemic that factually resulted in occurrence of emergency situation in health care and deteriorated access of population to medical care, is factor of failure in achieving main goals of the Federal project. To confirm or refute this hypothesis further research is needed.Federal and National projectscardiovascular diseaseshealth care efficiencyCOVID-19 pandemicintegrated assessmentMinmax techniqueфедеральные и национальные проектысердечно-сосудистые заболеваниярезультативность здравоохраненияпандемия COVID-19интегральная оценка результативностиметод MinMax[Gwartney J., Lawson R., Hall J. Economic Freedom of the World: 2012. Annual Report. Fraser Institute; 2012. 322 p.][United Nations Development Programme. Human Development Report 2020: The Next Frontier. Human Development and the Anthropocene. Режим доступа: http://hdr.undp.org/sites/default/files/hdr2020.pdf][Куделина О. В., Канева М. А. Капитал здоровья и эффективность региональных систем здравоохранения: соответствия и противоречия. Проблемы социальной гигиены, здравоохранения и истории медицины. 2022;30(1):24—32. doi: 10.32687/0869-866X-2022-30-1-24-32][Перхов В. И., Куделина О. В., Третьяков А. А. Оценка эффективности здравоохранения в субъектах Российской Федерации с использованием методологии Bloomberg. Менеджер здравоохранения. 2019;(8):6—13.][Bunker J. P., Frazier H. S., Mosteller F. Improving health: measuring effects of medical care. The Milbank Quarterly; 1994. P. 225—58.][Nolte E., McKee M. Does health care save lives? Avoidable mortality revisited. The Nuffield Trust; 2004. 138 р.][Kaplan G. A., Pamuk E. R., Lynch J. W., Cohen R. D., Balfour J. L. Inequality in income and mortality in the United States: analysis of mortality and potential pathways. BMJ. 1996;312(7037):999—1003. doi: 10.1136/bmj.312.7037.999][Macinko J., Starfield B., Erinosho T. The impact of primary healthcare on population health in low-and middle-income countries. J. Ambulat. Care Manag. 2009;32(2):150—71. doi: 10.1097/JAC.0b013e3181994221][Lackland D. T., Roccella E. J., Deutsch A. F., Fornage M. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315—53. doi: 10.1161/01.str.0000437068.30550.cf][Миллер А. Е., Миллер М. А. Региональные различия демографического развития федеральных округов Российской Федерации. Вестник Омского университета. Серия «Экономика». 2010;(4):88—93.][Улумбекова Г. Э., Гиноян А. Б., Петрачков И. В. Факторы влияния на смертность от новообразований и болезней системы кровообращения в РФ с 2019 по 2020 г. ОРГЗДРАВ: Новости. Мнения. Обучение. Вестник ВШОУЗ. 2021;7(3):4—23. doi: 10.33029/2411-8621-2021-7-3-4-23][Liu P. P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68—78. doi: 10.1161/CIRCULATIONAHA.120.047549][Madjid M., Safavi-Naeini P., Solomon S. D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831—40. doi: 10.1001/jamacardio.2020.1286][Guzik T. J., Mohiddin S. A., Dimarco A., Patel V., Kostas Savvatis K. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116(10):1666—87. doi: 10.1093/cvr/cvaa106][Teppone M. Phase Dynamics of the Covid-19 Pandemic. A Systematic Analysis of 213 Countries and Territories. Report 2. Problemi socialnoi gigieni, zdravookhranenia i istorii meditsimi. 2022;30(4):531—6. doi: 10.32687/0869-866X-2022-30-4-531-536][Vasudeva Rh., Challa A., Al Rifai M., Polana T., Duran B., Vindhyal M., Lewis E. F. Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States. Progr. Cardiovasc. Dis. 2022;74:122—6. doi: 10.1016/j.pcad.2022.09.002][Liu Y., Zhao Sh., Yang L., Aliaga-Linares L., He D. All-cause mortality during the COVID-19 pandemic in Peru. IJID Regions. 2022;5:177—9. doi: 10.1016/j.ijregi.2022.10.005][Liang Ch., Zhang W., Li Sh., Qin G. Coronary heart disease and COVID-19: A meta-analysis. Medicina Clínica (English Ed.). 2021;156(11):547—54. doi: 10.1016/j.medcle.2020.12.021][Liang X., Shi L., Wang Y., Xiao W., Duan G., Yang H., Wang Ya. The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates. J. Infect. 2020;81(3):e44—e47. doi: 10.1016/j.jinf.2020.06.060][Mesas A. E., Cavero-Redondo I., Alvarez-Bueno C., Sarria Cabrera M. A., Maffei de Andrade S., Sequi-Dominguez I. Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020;15(11):e0241742. doi: 10.1371/journal.pone.0241742][Liang X., Xu J., Xiao W., Shi L., Yang H. The association of diabeteswith COVID-19 disease severity: evidence from adjusted effect estimates. Hormones (Athens). 2021;20(2):409—14. doi: 10.1007/s42000-020-00259-x][Zhang R., Hao Y., Wang Y., Yang H. Significant association between ischemic heart disease and elevated risk for COVID-19 mortality: A meta-analysis. Am. J. Emerg. Med. 2022;55:95—7. doi: 10.1016/j.ajem.2022.03.010]